Synthetic lethality by co-targeting mitochondrial apoptosis and PI3K/Akt/mTOR signaling

被引：51

作者：

Fulda, Simone ^{[1
]}

机构：

[1] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60528 Frankfurt, Germany

来源：

MITOCHONDRION | 2014年 / 19卷

关键词：

Apoptosis; Mitochondria; Cell death; PI3K/Akt/mTOR; BH3; mimetics; BH3 MIMETIC ABT-737; IN-VITRO; ANTITUMOR-ACTIVITY; MAMMALIAN TARGET; LYMPHOMA-CELLS; CANCER; INHIBITOR; MCL-1; MTOR; PROTEINS;

D O I：

10.1016/j.mito.2014.04.011

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Small-molecule inhibitors that antagonize anti-apoptotic BcI-2 proteins such as BH3 mimetics are currently considered as promising cancer therapeutics to engage the mitochondrial pathway of apoptosis in cancer cells. However, BH3 mimetics may be effective as monotherapy only in cancers that critically depend on anti-apoptotic Bc1-2 proteins for their survival. Since most cancers have evolved multiple strategies to evade programmed cell death, concomitant targeting of several signaling transduction pathways becomes more and more relevant. The current review highlights the potential of combined inhibition of anti-apoptotic BcI-2 proteins together with the PI3K/Akt/mTOR signaling cascade to trigger apoptosis in cancer cells. (C) 2014 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

引用

页码：85 / 87

页数：3

共 21 条

[1] ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo [J].

Ackler, Scott ;

Xiao, Yu ;

Mitten, Michael J. ;

Foster, Kelly ;

Oleksijew, Anatol ;

Refici, Marion ;

Schlessinger, Sally ;

Wang, Baole ;

Chemburkar, Sanjay R. ;

Bauch, Joy ;

Tse, Christin ;

Frost, David J. ;

Fesik, Stephen W. ;

Rosenberg, Saul H. ;

Elmore, Steven W. ;

Shoemaker, Alex R. .

MOLECULAR CANCER THERAPEUTICS, 2008, 7 (10) :3265-3274

[2] Rapamycin passes the torch: a new generation of mTOR inhibitors [J].

Benjamin, Don ;

Colombi, Marco ;

Moroni, Christoph ;

Hall, Michael N. .

NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (11) :868-880

[3] Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing bak activation and bax translocation [J].

Chen, Shuang ;

Dai, Yun ;

Harada, Hisashi ;

Dent, Paul ;

Grant, Steven .

CANCER RESEARCH, 2007, 67 (02) :782-791

[4] AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity [J].

Chresta, Christine M. ;

Davies, Barry R. ;

Hickson, Ian ;

Harding, Tom ;

Cosulich, Sabina ;

Critchlow, Susan E. ;

Vincent, John P. ;

Ellston, Rebecca ;

Jones, Darren ;

Sini, Patrizia ;

James, Dominic ;

Howard, Zoe ;

Dudley, Phillippa ;

Hughes, Gareth ;

Smith, Lisa ;

Maguire, Sharon ;

Hummersone, Marc ;

Malagu, Karine ;

Menear, Keith ;

Jenkins, Richard ;

Jacobsen, Matt ;

Smith, Graeme C. M. ;

Guichard, Sylvie ;

Pass, Martin .

CANCER RESEARCH, 2010, 70 (01) :288-298

[5] Targeting PI3K signalling in cancer: opportunities, challenges and limitations [J].

Engelman, Jeffrey A. .

NATURE REVIEWS CANCER, 2009, 9 (08) :550-562

[6] The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer [J].

Folkes, Adrian J. ;

Ahmadi, Khatereh ;

Alderton, Wendy K. ;

Alix, Sonia ;

Baker, Stewart J. ;

Box, Gary ;

Chuckowree, Irina S. ;

Clarke, Paul A. ;

Depledge, Paul ;

Eccles, Suzanne A. ;

Friedman, Lori S. ;

Hayes, Angela ;

Hancox, Timothy C. ;

Kugendradas, Arumugam ;

Lensun, Letitia ;

Moore, Pauline ;

Olivero, Alan G. ;

Pang, Jodie ;

Patel, Sonal ;

Pergl-Wilson, Giles H. ;

Raynaud, Florence I. ;

Robson, Anthony ;

Saghir, Nahid ;

Salphati, Laurent ;

Sohal, Sukhjit ;

Ultsch, Mark H. ;

Valenti, Melanie ;

Wallweber, Heidi J. A. ;

Wan, Nan Chi ;

Wiesmann, Christian ;

Workman, Paul ;

Zhyvoloup, Alexander ;

Zvelebil, Marketa J. ;

Shuttleworth, Stephen J. .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (18) :5522-5532

[7] Targeting IAP proteins for therapeutic intervention in cancer [J].

Fulda, Simone ;

Vucic, Domagoj .

NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (02) :109-124

[8] Targeting mitochondria for cancer therapy [J].

Fulda, Simone ;

Galluzzi, Lorenzo ;

Kroemer, Guido .

NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (06) :447-464

[9] Tumor resistance to apoptosis [J].

Fulda, Simone .

INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) :511-515

[10] Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia [J].

Konopleva, Marina ;

Contractor, Rooha ;

Tsao, Twee ;

Samudio, Ismael ;

Ruvalo, Peter P. ;

Kitada, Shinichi ;

Deng, Xingming ;

Zhai, Dayong ;

Shi, Yue-Xi ;

Sneed, Thomas ;

Verhaegen, Monique ;

Soengas, Maria ;

Ruvolo, Vivian R. ;

McQueen, Teresa ;

Schober, Wendy D. ;

Watt, Julie C. ;

Jiffar, Tilahun ;

Ling, Xiaoyang ;

Marini, Frank C. ;

Harris, David ;

Dietrich, Martin ;

Estrov, Zeev ;

McCubrey, James ;

May, W. Stratford ;

Reed, John C. ;

Andreeff, Michael .

CANCER CELL, 2006, 10 (05) :375-388

← 1 2 3 →